Barely Significant
← all excerpts

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia.

Clin Interv Aging · 2011 · PMC3131986 · PMID 21753871

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
The differences versus placebo were highly significant ( P < 0.001) for both active compounds, whereas the comparison between silodosin and tamsulosin did not show a statistically significant difference.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.